LEPR and breast carcinoma: By menopausal status, LEPR gene rs1137100-AA genotype carriers conferred a significantly reduced risk of breast cancer compared with GG genotype carriers (OR: 0.23, 95% CI: 0.07 to 0.82) in both premenopausal and postmenopausal women.